MétaCan
Menu
Back to cohort
Record W2946398113 · doi:10.1055/s-0039-1686649

Baseline-Charakteristika von Patienten mit chronischer Rhinosinusitis mit nasalen Polypen (mit und ohne Asthma) in SINUS-52, einer randomisierten, doppel-blinden, Phase-3-Studie von Dupilumab

2019· article· de· W2946398113 on OpenAlexaff
Claus Bachert, Martin Desrosiers, Joaquim Mullol, J.F. Maspero, Martin Wagenmann, Isa Niemann, Asif Khan, Siddhesh Kamat, Nikhil Amin, L. Mannent

Bibliographic record

VenueLaryngo-Rhino-Otologie · 2019
Typearticle
Languagede
FieldMedicine
TopicSinusitis and nasal conditions
Canadian institutionsCentre Hospitalier de l’Université de Montréal
Fundersnot available
KeywordsDupilumabMedicineChronic rhinosinusitisAtopic dermatitisDermatologyInternal medicine

Abstract

fetched live from OpenAlex

Einleitung: Chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) ist eine vorwiegend Typ-2-vermittelte Erkrankung mit hoher Symptomlast u. schlechter Lebensqualität. Dupilumab, ein humaner IL-4Rα-mAb, inhibiert die für die Typ-2-Entzündung zentralen Zytokine IL-4/IL-13 und ist bei Erwachsenen für unkontrollierte mittlere bis schwere atopische Dermatitis sowie in den USA für Patienten (Pat) ab 12 Jahren für mittleres bis schweres eosinophiles oder Steroid-abhängiges Asthma indiziert. In einer Phase-2a-Studie verbesserte Dupilumab endoskopische, radiologische, klinische u. subjektive Beschwerden in CRSwNP Pat. Wir präsentieren Baseline-Charakteristika von CRSwNP-Pat unter täglichen nasalen Steroiden aus der neuen Dupilumab Phase-3-Studie (SINUS-52; NCT02898454). Methoden: Pat wurden im Verhältnis 1: 1: 1 randomisiert u. erhielten über 52 Wochen Placebo alle 2 Wochen (q2w), Dupilumab 300 mg q2w oder Dupilumab 300 mg q2w (für 24 Wochen) und q4w (restl. 28 Wochen). Ergebnisse: Von 448 Pat waren 37,7% weiblich (mittleres [SD] Alter 52,0 [12,5] Jahre). Die mittlere [SD] CRSwNP-Erkrankungsdauer war 10,9 [9,6] Jahre, 58,3% der Pat hatten ≥1 vorherigen sinonasalen Eingriff, 80,1% erhielten in den letzten 2 Jahren systemische Kortikosteroide. 82,4% der Pat hatten eine Typ-2-Komorbidität wie Asthma (59,6%) o. N-ERD (26,8%). Die mittleren Werte [SD] bei Einschluss waren: Polypenscore, 6,1 [1,2]; Nasale Kongestion, 2,4 [0,6]; SNOT-22, 51,9 [20,9]; UPSIT, 13,6 [8,0]; CT LMK, 18,0 [3,8]; u. VAS für Syptomschwere, 8,0 [2,1]. Schlussfolgerung: Die Baseline-Charakteristika zeigen eine Population mit schwerer unkontrollierter CRSwNP unter Standardmedikation, was den Bedarf an zusätzlichen therapeutischen Alternativen verdeutlicht. Die meisten Pat hatten Asthma oder eine andere Typ-2-Komorbidität. Publication History Publication Date: 23 April 2019 (online) © 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Stuttgart · New York

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.300
Teacher spread0.278 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueLaryngo-Rhino-OtologieSame topicSinusitis and nasal conditionsFrench-language works237,207